Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
medium right arrow graphic Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
medium right arrow graphic Attach to Form 990.
medium right arrow graphic Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2022
Open to Public Inspection
Name of the organization
Rutland Hospital Inc
 
Employer identification number

03-0183483
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
Yes
 
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2022
Page 2

Schedule J (Form 990) 2022
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC (C) Retirement and other deferred compensation (D) Nontaxable
benefits
(E) Total of columns
(B)(i)-(D)
(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation
(ii) Bonus & incentive
compensation
(iii) Other reportable compensation
1Alison Davis MD
 
Director END 02/23
(i)

(ii)
414,638
-------------
0
34,283
-------------
0
2,061
-------------
0
19,825
-------------
0
24,586
-------------
0
495,393
-------------
0
0
-------------
0
2Matthew Conway MD
 
Director END 02/23
(i)

(ii)
432,920
-------------
0
187,030
-------------
0
6,568
-------------
0
25,925
-------------
0
24,630
-------------
0
677,073
-------------
0
0
-------------
0
3Phillip R Lapp MD
 
Director
(i)

(ii)
283,440
-------------
0
97,392
-------------
0
23,437
-------------
0
31,700
-------------
0
27,777
-------------
0
463,746
-------------
0
0
-------------
0
4Micheal DiMeola MD
 
Director BEG 03/23
(i)

(ii)
242,683
-------------
0
28,722
-------------
0
439
-------------
0
450
-------------
0
12,352
-------------
0
284,646
-------------
0
0
-------------
0
5Claudio D Fort
 
President/CEO END 12/22
(i)

(ii)
614,983
-------------
0
56,330
-------------
0
33,385
-------------
0
80,061
-------------
0
27,983
-------------
0
812,742
-------------
0
0
-------------
0
6Judi K Fox
 
CFO END; PRESIDENT/INTERIM CFO BEG 06/23
(i)

(ii)
361,515
-------------
0
68,178
-------------
0
1,868
-------------
0
32,025
-------------
0
27,835
-------------
0
491,421
-------------
0
0
-------------
0
7Thomas E Frank
 
VP Medical Group Operations END 04/23
(i)

(ii)
322,832
-------------
0
25,767
-------------
0
4,717
-------------
0
13,725
-------------
0
1,329
-------------
0
368,370
-------------
0
0
-------------
0
8Elizabeth A Kyhill
 
VP Medical Group Operations BEG 07/23
(i)

(ii)
194,029
-------------
0
21,459
-------------
0
408
-------------
0
9,745
-------------
0
2,123
-------------
0
227,764
-------------
0
0
-------------
0
9Melbourne D Boynton MD
 
Orthopedic Surgeon/Medical Officer
(i)

(ii)
628,556
-------------
0
520,186
-------------
0
28,024
-------------
0
32,025
-------------
0
17,742
-------------
0
1,226,533
-------------
0
0
-------------
0
10Stanley M Shapiro MD
 
Cardiologist/Medical Director
(i)

(ii)
289,958
-------------
0
369,334
-------------
0
26,988
-------------
0
32,025
-------------
0
17,382
-------------
0
735,687
-------------
0
0
-------------
0
11Brad L Jimmo MD
 
General Surgery/Medical Director
(i)

(ii)
417,718
-------------
0
84,826
-------------
0
3,924
-------------
0
25,925
-------------
0
9,097
-------------
0
541,490
-------------
0
0
-------------
0
12Rick Hildebrant MD
 
Hospitalists/Medical Director
(i)

(ii)
381,061
-------------
0
43,110
-------------
0
873
-------------
0
19,825
-------------
0
27,277
-------------
0
472,146
-------------
0
0
-------------
0
13Jonathan Reynolds
 
VP Clinical Services
(i)

(ii)
271,765
-------------
0
36,860
-------------
0
6,409
-------------
0
13,725
-------------
0
27,752
-------------
0
356,511
-------------
0
0
-------------
0
14Brian Kerns
 
VP Human Resources
(i)

(ii)
273,000
-------------
0
22,559
-------------
0
2,659
-------------
0
13,725
-------------
0
24,461
-------------
0
336,404
-------------
0
0
-------------
0
15Roger F Wakeman
 
VP Support Services
(i)

(ii)
227,211
-------------
0
48,600
-------------
0
1,965
-------------
0
1,121
-------------
0
7,565
-------------
0
286,462
-------------
0
0
-------------
0
16Carol M Egan
 
Interim Chief Nursing Officer END 11/22
(i)

(ii)
235,959
-------------
0
21,368
-------------
0
5,440
-------------
0
9,779
-------------
0
911
-------------
0
273,457
-------------
0
0
-------------
0
17Kelly O Watson
 
VP Chief Nursing Officer
(i)

(ii)
126,082
-------------
0
74,179
-------------
0
190
-------------
0
284
-------------
0
8,467
-------------
0
209,202
-------------
0
0
-------------
0
18Traci M Moore
 
Senior Director Development Comm Relations
(i)

(ii)
178,832
-------------
0
12,545
-------------
0
730
-------------
0
9,007
-------------
0
27,403
-------------
0
228,517
-------------
0
0
-------------
0
19TODD GREGORY MD
 
PHYSICIAN/MEDICAL DIRECTOR
(i)

(ii)
490,583
-------------
0
6,009
-------------
0
2,551
-------------
0
25,925
-------------
0
24,682
-------------
0
549,750
-------------
0
0
-------------
0
20ANDREW P DENICCO MD
 
PHYSICIAN/ASSISTANT MEDICAL DIRECTOR
(i)

(ii)
264,975
-------------
0
133,331
-------------
0
270
-------------
0
19,825
-------------
0
12,083
-------------
0
430,484
-------------
0
0
-------------
0
21Harvey S Reich MD
 
Medical Director Critical Care
(i)

(ii)
1,252,110
-------------
0
105,186
-------------
0
20,179
-------------
0
25,675
-------------
0
19,144
-------------
0
1,422,294
-------------
0
0
-------------
0
22Eric Marsh MD
 
Orthopedics
(i)

(ii)
581,282
-------------
0
643,322
-------------
0
967
-------------
0
25,925
-------------
0
18,407
-------------
0
1,269,903
-------------
0
0
-------------
0
23Michael Robertello MD
 
Cardiology
(i)

(ii)
433,353
-------------
0
430,376
-------------
0
33,223
-------------
0
25,925
-------------
0
24,633
-------------
0
947,510
-------------
0
0
-------------
0
24Ernest M Bove MD
 
Urology
(i)

(ii)
486,901
-------------
0
240,382
-------------
0
34,344
-------------
0
25,925
-------------
0
17,070
-------------
0
804,622
-------------
0
0
-------------
0
25John W Karl MD
 
Orthopedics
(i)

(ii)
398,758
-------------
0
328,795
-------------
0
433
-------------
0
19,825
-------------
0
23,792
-------------
0
771,603
-------------
0
0
-------------
0
26John Wallace
 
FORMER General Counsel Co
(i)

(ii)
51,171
-------------
0
0
-------------
0
375,426
-------------
0
2,303
-------------
0
0
-------------
0
428,900
-------------
0
0
-------------
0
Schedule J (Form 990) 2022
Page 3

Schedule J (Form 990) 2022
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
Schedule J, Part I, Line 4a Severance or change-of-control payment DURING 2022, JOHN WALLACE RECEIVED A SEVERANCE PAYMENT OF $375,426.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan CLAUDIO D. FORT IS COVERED WITH A 457(F) SUPPLEMENTAL RETIREMENT AGREEMENT (SERP). IN THE CURRENT YEAR, A CONTRIBUTION OF $66,336 WAS MADE.
Schedule J, Part I, Line 5a Compensation contingent on revenues of the organization PHYSICIANS EARN COMPENSATION BASED UPON THEIR PRODUCTIVITY AGAINST ESTABLISHED TARGETS. INCREASED PRODUCTIVITY IS DIRECTLY RELATED TO INCREASED REVENUES FOR THE ORGANIZATION.
Schedule J (Form 990) 2022

Additional Data


Software ID: 22016089
Software Version: 2022v5.0